Share this event

The Future of mRNA Therapeutics 

mRNA became an everyday topic with the development of the COVID-19 mRNA vaccines, but where are we are we going now? In a session lead by Gairdner Early Career Investigators, leaders in the understanding and development of mRNA therapeutics will share their work and discuss the potential of mRNA for treating disease and how to make it work in clinical settings.


Yizhou Dong, Icahn School of Medicine at Mount Sinai

Christian J. Kastrup, Versiti Blood Research Institute

Sarah Hedtrich, Charité – Universitätsmedizin Berlin

Don't miss this opportunity to gain valuable insights from world-renowned experts in the mRNA therapeutics. Reserve your spot today and mark your calendars!


12:00 pm


Bowen Li


2022 Gairdner Early Career Investigator; Assistant Professor, Department of Pharmaceutical Sciences, University of Toronto; Adjunct Assistant Professor, Institute of Biomedical Engineering, UofT; Faculty member, PRiME – A Next-Generation Precision Medicine Initiative

Anna Blakney 


2022 Gairdner Early Career Investigator; Assistant Professor,  Michael Smith Laboratories and School of Biomedical Engineering, University of British Columbia

12:05 pm

Lipid nanoparticles enabled mRNA therapeutics

Yizhou Dong PhD

Professor, Icahn Genomics Institute Department of Immunology and Immunotherapy Department of Oncological Sciences Precision Immunology Institute Tisch Cancer Institute Friedman Brain Institute Biomedical Engineering and Imaging Institute Icahn School of Medicine at Mount Sinai

12:17 pm

Replacing and enhancing blood proteins using mRNA lipid nanoparticles

Christian J. Kastrup PhD

Senior Investigator Versiti Blood Research Institute Professor Department of Surgery, Division of Trauma and Acute Care Surgery, and Departments of Biochemistry, Biomedical Engineering, and Pharmacology and Toxicology Medical College of Wisconsin Affiliate Professor Michael Smith Laboratories University of British Columbia

12:30 pm

How to efficiently deliver gene therapies across restrictive epithelial barriers

Sarah Hedtrich PhD
Associated Professor, Berlin Institute of Health at Charité, Center of Biological Design, Department of Internal Medicine, Infectiology, Respiratory-, and Critical-Care-Medicine of the Charité – Universitätsmedizin Berlin. Affiliated Professor, Faculty of Pharmaceutical Sciences, The University of British Columbia

12:40 pm

Roundtable Discussion


Anna Blakney, Bowen Li, Yizhou Dong, Christian Kastrup, Sarah Hedtrich

1:15 pm

Concluding remarks

Bowen Li